Melanocortin signaling and anorexia in chronic disease states

Annals of the New York Academy of Sciences

Volumn 994, Issue , 2003, Pages 275-281

  Wisse, Brent E ^a   Schwartz, Michael W ^a   Cummings, David E ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Division of Metabolism   (United States)

Author keywords

Cachexia; Cancer; Cytokine; Definition; Inflammation

Indexed keywords

AGOUTI RELATED PROTEIN; CYTOKINE; HORMONE ANTAGONIST; INTERLEUKIN 1; INTERLEUKIN 6; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN ANTAGONIST; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANOREXIA; CACHEXIA; CANCER; CHRONIC DISEASE; CONFERENCE PAPER; ENERGY BALANCE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPERPHAGIA; INFLAMMATION; KNOCKOUT MOUSE; LIPID STORAGE; NONHUMAN; OBESITY; PATHOGENESIS; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

AGOUTI; BACTERIA (MICROORGANISMS); NEGIBACTERIA; RODENTIA;

EID: 0038389368     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03190.x     Document Type: Conference Paper

References (32)

1. CONE, R.D. 1999. The central melanocortin system and energy homeostasis. Trends Endocrinol. Metab. 10: 211-216.
2. BOSTON, B.A. 2001. Pro-opiomelanocortin and weight regulation: from mice to men. J. Pediatr. Endocrinol. Metab. 14: 1409-1416.
3. YORK, D.A. 1999. Peripheral and central mechanisms regulating food intake and macronutrient selection. Obes. Surg. 9: 471-479.
4. CUMMINGS, D.E. & M.W. SCHWARTZ. 2000. Melanocortins and body weight: a tale of two receptors. Nat. Genet. 26: 8-9.
5. SCHWARTZ, M.W. et al. 2000. Central nervous system control of food intake. Nature 404: 661-671.
6. BRUERA, E. 1997. ABC of palliative care. Anorexia, cachexia, and nutrition. Br. Med. J. 315: 1219-1222.
7. GRUNFELD, C. & D.P. KOTLER. 1992. Pathophysiology of the AIDS wasting syndrome. AIDS Clin. Rev. 1992: 191-224.
8. INUI, A. 2002. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J. Clin. 52: 72-91.
9. ALBRECHT, J.T. & T.W. CANADA. 1996. Cachexia and anorexia in malignancy. Hematol. Oncol. Clin. North Am. 10: 791-800.
10. BRUERA, E. 1998. Pharmacological treatment of cachexia: any progress? Support Care Cancer 6: 109-113.
11. MEGUID, M.M. et al. 1999. Differential feeding patterns induced by tumor growth and by TPN. Nutrition 15: 555-562.
12. MARKS, D.L., N. LING & R.D. CONE. 2001. Role of the central melanocortin system in cachexia. Cancer Res. 61: 1432-1438.
13. MYSTKOWSKI, P. et al. 2000. Validation of whole-body magnetic resonance spectroscopy as a tool to assess murine body composition. Int. J. Obes. Relat. Metab. Disord. 24: 719-724.
14. PLATA-SALAMAN, C.R. 1996. Anorexia during acute and chronic disease. Nutrition 12: 69-78.
15. PLATA-SALAMAN, C.R. 2000. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 16: 1009-1012.
16. INUI, A. 1999. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res. 59: 4493-4501.
17. TISDALE, M.J. 1997. Biology of cachexia. J. Natl. Cancer Inst. 89: 1763-1773.
18. CERAMI, A. et al. 1987. Cachectin: a pluripotent hormone released during the host response to invasion, Recent Prog. Horm. Res. 43: 99-112.
19. MEGUID, M.M. et al. 2000. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 16: 843-857.
20. MALTONI, M. et al. 1997. Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients. Support Care Cancer 5: 130-135.
21. NOGUCHI, Y. et al. 1996. Are cytokines possible mediators of cancer cachexia? Surg. Today 26: 467-475.
22. CABAL-MANZANO, R. et al. 2001. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss. Br. J. Cancer 84: 1599-1601.
23. CERIANI, G. et al. 1994. Central neurogenic antiinflammatory action of alpha-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 59: 138-143.
24. HUANG, Q.H., V.J. HRUBY & J.B. TATRO. 1999. Role of central melanocortins in endotoxin-induced anorexia. Am. J. Physiol. 276: R864-R871.
25. GRUNFELD, C. et al. 1996. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest. 97: 2152-2157.
26. FAGGIONI, R. et al. 1997. LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. Am. J. Physiol, 273: R181-R186.
27. LOPEZ-SORIANO, J. et al. 1999. Leptin and tumor growth in rats. Int. J. Cancer 81: 726-729.
28. WISSE, B.E. et al. 2001. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 142: 3292-3301.
29. LAWRENCE, C.B. & N.J. ROTHWELL. 2001. Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat. J. Neuroendocrinol. 13: 490-495.
30. PRITCHARD, L.E., A.V. TURNBULL & A. WHITE. 2002. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J. Endocrinol. 172:411-421.
31. NIJENHUIS, W.A., J. OOSTEROM & R.A. ADAN. 2001. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15: 164-171.
32. SCHWARTZ, M.W. et al. 1997. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46: 2119-2123.